ArriVent BioPharma, Inc.
AVBP
Jodie situation report
ArriVent BioPharma, Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 7 of 8 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.
- At least 6 of 8 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as MLTX begins moving with the group.
Invalidation: The live read weakens if participation falls to 2 of 8 members or fewer.
Who this business touches
The relationships behind AVBP
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
WXILYFiling-linked namesupplierMar 5, 2026 ▾
“Currently, we rely on, and have agreements with, two third-party contract manufacturers, Zhejiang Raybow Pharmaceutical Company., Ltd.”
AZNAstraZeneca PLCcompetitorMay 11, 2026 ▾
“We believe that our current and future competition for resources and eventually for customers comes from companies that are commercializing or developing candidates targeting EGFRm-positive NSCLC, including, but not limited to, 23 Table of Contents AstraZenec…”
Depended on by
ORICOric Pharmaceuticals, Inc.partnerMay 4, 2026 ▾
“We are also aware of several companies developing small molecule inhibitors against EGFR exon 20 insertion mutations and EGFR atypical mutations that are currently in clinical trials, including Cullinan Therapeutics in collaboration with Taiho Pharmaceutical,…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
AVBP is currently a Participant in the organic co-movement group Clinical Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.